Dr. Read is a general partner of Alloy Ventures, a venture capital firm. He received a B.S. in psychology and biology from Rice University and later received a medical degree from the University of Texas Health Science Center at San Antonio. In 1989, he co-founded Affymax NV, a biopharmaceutical company. Later on, he founded Aviron, a biopharmaceutical company, and served as its Chief Executive Officer until 1999. Dr. Read is a member of the board of directors of various private companies. He has also received several awards for co-inventing the technology underlying the Affymetrix GeneChip. Dr. Read will bring his expertise in vaccine discovery and product development to VIC.